These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29051272)

  • 1. Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.
    van Manen MJG; Birring SS; Vancheri C; Vindigni V; Renzoni E; Russell AM; Wapenaar M; Cottin V; Wijsenbeek MS
    Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29051272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MODERN APPROACH TO THERAPY OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS].
    Tsvetkova OA; Voronkova OO; Buyanova OE
    Klin Med (Mosk); 2017; 95(3):281-5. PubMed ID: 30303652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment.
    Nathan SD; Costabel U; Albera C; Behr J; Wuyts WA; Kirchgaessler KU; Stauffer JL; Morgenthien E; Chou W; Limb SL; Noble PW
    Respir Med; 2019 Jul; 153():44-51. PubMed ID: 31153107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and safety of pirfenidone for idiopathic pulmonary fibrosis.
    Marcos Ribes B; Sancho-Chust JN; Talens A; Arlandis M; Herraiz P; Chiner E; Aznar T
    Eur J Hosp Pharm; 2020 Nov; 27(6):350-354. PubMed ID: 33020058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pirfenidone in idiopathic pulmonary fibrosis.
    Swigris J; Fairclough D
    Eur Respir J; 2010 Sep; 36(3):695-6; author reply 696-8. PubMed ID: 20930209
    [No Abstract]   [Full Text] [Related]  

  • 6. Intraindividual response to treatment with pirfenidone in idiopathic pulmonary fibrosis.
    Loeh B; Drakopanagiotakis F; Bandelli GP; von der Beck D; Tello S; Cordani E; Rizza E; Barrocu L; Markart P; Seeger W; Guenther A; Albera C
    Am J Respir Crit Care Med; 2015 Jan; 191(1):110-3. PubMed ID: 25551350
    [No Abstract]   [Full Text] [Related]  

  • 7. Real world experiences: pirfenidone is well tolerated in patients with idiopathic pulmonary fibrosis.
    Chaudhuri N; Duck A; Frank R; Holme J; Leonard C
    Respir Med; 2014 Jan; 108(1):224-6. PubMed ID: 24269005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-fibrotics as novel therapy for idiopathic pulmonary fibrosis].
    Funke-Chambour M; Geiser T
    Ther Umsch; 2016; 73(1):25-9. PubMed ID: 26884217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cough in idiopathic pulmonary fibrosis: more than just a nuisance.
    Vigeland CL; Horton MR
    Lancet Respir Med; 2016 Aug; 4(8):600-601. PubMed ID: 27346585
    [No Abstract]   [Full Text] [Related]  

  • 10. An Open-Label Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (RECAP).
    Costabel U; Albera C; Lancaster LH; Lin CY; Hormel P; Hulter HN; Noble PW
    Respiration; 2017; 94(5):408-415. PubMed ID: 28898890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation.
    Maher TM; Lancaster LH; Jouneau S; Morrison L; Lederer DJ; Molina-Molina M; Bendstrup E; Kirchgaessler KU; Gilberg F; Axmann J; Petzinger U; Noble PW
    Ann Am Thorac Soc; 2019 Jul; 16(7):927-930. PubMed ID: 30950636
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Behr J; Bendstrup E; Crestani B; Günther A; Olschewski H; Sköld CM; Wells A; Wuyts W; Koschel D; Kreuter M; Wallaert B; Lin CY; Beck J; Albera C
    Lancet Respir Med; 2016 Jun; 4(6):445-53. PubMed ID: 27161257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis.
    Flaherty KR; Fell CD; Huggins JT; Nunes H; Sussman R; Valenzuela C; Petzinger U; Stauffer JL; Gilberg F; Bengus M; Wijsenbeek M
    Eur Respir J; 2018 Aug; 52(2):. PubMed ID: 29946005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Patient with Idiopathic Pleuroparenchymal Fibroelastosis Showing a Sustained Pulmonary Function due to Treatment with Pirfenidone.
    Sato S; Hanibuchi M; Takahashi M; Fukuda Y; Morizumi S; Toyoda Y; Goto H; Nishioka Y
    Intern Med; 2016; 55(5):497-501. PubMed ID: 26935370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of the clinical effects of pirfenidone on idiopathic pulmonary fibrosis.
    Arai T; Inoue Y; Sasaki Y; Tachibana K; Nakao K; Sugimoto C; Okuma T; Akira M; Kitaichi M; Hayashi S
    Respir Investig; 2014 Mar; 52(2):136-43. PubMed ID: 24636270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rare case of drug-induced hypersensitivity syndrome by pirfenidone for idiopathic pulmonary fibrosis.
    Suda K; Kamiya K; Chiang B; Okada H; Mato N; Maekawa T; Komine M; Murata S; Ohtsuki M
    Allergol Int; 2018 Jul; 67(3):425-426. PubMed ID: 29588165
    [No Abstract]   [Full Text] [Related]  

  • 17. Pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse events.
    Costabel U; Bendstrup E; Cottin V; Dewint P; Egan JJ; Ferguson J; Groves R; Hellström PM; Kreuter M; Maher TM; Molina-Molina M; Nordlind K; Sarafidis A; Vancheri C
    Adv Ther; 2014 Apr; 31(4):375-91. PubMed ID: 24639005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pirfenidone-induced phototoxic reaction in a patient with idiopathic pulmonary fibrosis.
    Woo YJ; Sohn KM; Kang H; Kim JE
    Eur J Dermatol; 2017 Oct; 27(5):545-546. PubMed ID: 29084642
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study.
    Tzouvelekis A; Ntolios P; Karampitsakos T; Tzilas V; Anevlavis S; Bouros E; Steiropoulos P; Koulouris N; Stratakos G; Froudarakis M; Bouros D
    Pulm Pharmacol Ther; 2017 Oct; 46():48-53. PubMed ID: 28843616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Colitis Associated with Pirfenidone Use in Idiopathic Pulmonary Fibrosis.
    Fiddler CA; Simler N; Parfrey H; Miremadi A; Chilvers ER
    Ann Am Thorac Soc; 2016 Aug; 13(8):1430-2. PubMed ID: 27509160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.